-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Nuvation Bio with Neutral Rating, Announces Price Target of $10

Benzinga·01/07/2026 20:24:12
语音播报
UBS analyst Michael Yee initiates coverage on Nuvation Bio (NYSE:NUVB) with a Neutral rating and announces Price Target of $10.